Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis.

Nordmann AJ, Briel M, Bucher HC.

Eur Heart J. 2006 Dec;27(23):2784-814. Epub 2006 Oct 4. Review.

PMID:
17020889
2.

A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.

Schömig A, Dibra A, Windecker S, Mehilli J, Suárez de Lezo J, Kaiser C, Park SJ, Goy JJ, Lee JH, Di Lorenzo E, Wu J, Jüni P, Pfisterer ME, Meier B, Kastrati A.

J Am Coll Cardiol. 2007 Oct 2;50(14):1373-80. Epub 2007 Aug 21. Review.

3.
4.

The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials.

Kumbhani DJ, Bavry AA, Kamdar AR, Helton TJ, Bhatt DL.

Am Heart J. 2008 Apr;155(4):640-7. doi: 10.1016/j.ahj.2007.11.017. Epub 2008 Feb 21. Review.

PMID:
18371470
5.

A systematic review and economic analysis of drug-eluting coronary stents available in Australia.

Lord SJ, Howard K, Allen F, Marinovich L, Burgess DC, King R, Atherton JJ.

Med J Aust. 2005 Nov 7;183(9):464-71. Review.

PMID:
16274347
6.

Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction.

Pasceri V, Patti G, Speciale G, Pristipino C, Richichi G, Di Sciascio G.

Am Heart J. 2007 May;153(5):749-54. Review.

PMID:
17452148
8.

Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents.

Iijima R, Mehilli J, Schömig A, Kastrati A.

Minerva Cardioangiol. 2006 Oct;54(5):539-55. Review.

PMID:
17019392
9.

Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from seven randomized trials.

Iijima R, Byrne RA, Dibra A, Ndrepepa G, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Suttorp MJ, Violini R, Schömig A, Kastrati A.

Rev Esp Cardiol. 2009 Apr;62(4):354-64. Review. English, Spanish.

10.

A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease.

Sidhu S, Shafiq N, Malhotra S, Pandhi P, Grover A.

Br J Clin Pharmacol. 2006 Jun;61(6):720-6. Review.

11.

Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.

Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Seyfarth M, Varenne O, Dirksen MT, Percoco G, Varricchio A, Pittl U, Syvänne M, Suttorp MJ, Violini R, Schömig A.

Eur Heart J. 2007 Nov;28(22):2706-13. Epub 2007 Sep 27. Review.

PMID:
17901079
12.

How to treat diabetic patients with multivesseal disease in the DES era.

Pagnotta P, Cabbavale M, Briguori C.

Minerva Cardioangiol. 2006 Oct;54(5):557-69. Review.

PMID:
17019393
13.

Clinical benefits of drug-eluting stents: results from RAVEL and beyond.

Fennessy MM, Borden WB.

J Cardiovasc Nurs. 2006 Nov-Dec;21(6):442-50. Review.

PMID:
17293733
14.

Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials.

Stettler C, Allemann S, Egger M, Windecker S, Meier B, Diem P.

Heart. 2006 May;92(5):650-7. Epub 2005 Oct 26. Review.

15.

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.

Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P.

Lancet. 2007 Sep 15;370(9591):937-48. Review.

PMID:
17869634
16.

Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis.

Hassan AK, Bergheanu SC, Stijnen T, van der Hoeven BL, Snoep JD, Plevier JW, Schalij MJ, Wouter Jukema J.

Eur Heart J. 2010 May;31(10):1172-80. doi: 10.1093/eurheartj/ehn553. Epub 2009 Jan 21. Review.

PMID:
19158118
17.

Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.

Piscione F, Piccolo R, Cassese S, Galasso G, Chiariello M.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):323-32. doi: 10.1002/ccd.22017. Review.

PMID:
19360858
18.

Xience V everolimus-eluting coronary stent.

Kukreja N, Onuma Y, Serruys PW.

Expert Rev Med Devices. 2009 May;6(3):219-29. doi: 10.1586/erd.09.1. Review.

PMID:
19419279
19.

Drug-eluting stents: an early systematic review to inform policy.

Hill RA, Dündar Y, Bakhai A, Dickson R, Walley T.

Eur Heart J. 2004 Jun;25(11):902-19. Review.

PMID:
15172462
20.

Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis.

Stettler C, Allemann S, Wandel S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, De Carlo M, Erglis A, Chechi T, Ortolani P, Schalij MJ, Diem P, Meier B, Windecker S, Jüni P.

BMJ. 2008 Aug 29;337:a1331. doi: 10.1136/bmj.a1331. Review.

Supplemental Content

Support Center